MPLT
NASDAQ · Biotechnology
Maplight Therapeutics Inc
$12.17
-1.11 (-8.36%)
Open$13.28
Previous Close$13.28
Day High$13.61
Day Low$12.09
52W High$40.43
52W Low$9.10
Volume—
Avg Volume2.49M
Market Cap565.97M
P/E Ratio—
EPS$-2.60
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+419.2% upside
Current
$12.17
$12.17
Target
$63.19
$63.19
$44.21
$63.19 avg
$83.67
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 110.57M | 109.60M | 110.00M |
| Net Income | -5,057,192 | -4,807,023 | -6,303,306 |
| Profit Margin | -4.6% | -4.4% | -5.7% |
| EBITDA | -7,551,548 | -8,325,034 | -7,754,101 |
| Free Cash Flow | -7,533,825 | -4,832,804 | -6,604,673 |
| Rev Growth | +23.3% | +7.4% | -2.1% |
| Debt/Equity | 0.30 | 0.38 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |